Cgpc
Cgpc, officially known as Chang Gung Pharmaceutical Corporation, is a prominent player in the pharmaceutical industry, headquartered in Taiwan (TW). Established in 1964, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, including prescription medications and over-the-counter solutions. With a strong operational presence across Asia, Cgpc is renowned for its commitment to innovation and quality, particularly in the fields of biotechnology and generic pharmaceuticals. The company’s core offerings are distinguished by their rigorous adherence to international standards and a focus on patient safety. Cgpc has achieved notable recognition in the market, positioning itself as a trusted name in healthcare. Its dedication to research and development has led to several key milestones, solidifying its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Cgpc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Plastic production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cgpc's score of 23 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cgpc's reported carbon emissions
In 2023, Cgpc reported total carbon emissions of approximately 15130000 kg CO2e for Scope 1, 16830000 kg CO2e for Scope 2, and 139490000 kg CO2e for Scope 3, amounting to a total of about 171000000 kg CO2e. This data reflects a comprehensive disclosure of emissions across all three scopes, indicating a commitment to transparency in their environmental impact. Comparatively, in 2022, Cgpc's emissions were significantly higher, with Scope 1 at approximately 151239000 kg CO2e, Scope 2 at about 168141000 kg CO2e, and Scope 3 reaching approximately 1394848000 kg CO2e. This suggests a notable reduction in emissions across all scopes from 2022 to 2023. Despite these figures, Cgpc has not established specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company does not appear to inherit emissions data from a parent organization, maintaining its own reporting standards. Overall, Cgpc's emissions data highlights the company's substantial carbon footprint, particularly in Scope 3 emissions, while also showcasing a year-on-year reduction in total emissions. The lack of formal reduction commitments suggests an area for potential improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 5,066,000,000 | 000.0 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 2 | 9,425,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | 00,000.0 | 0,000,000,000 | 0,000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cgpc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
